We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.63%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$82.8B
AUM Growth
+$1.44B
(+1.8%)
Cap. Flow
-$2.02B
Cap. Flow
% of AUM
-2.43%
Top 10 Holdings %
Top 10 Hldgs %
16.17%
Holding
1,933
New
90
Increased
882
Reduced
857
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
eBay
EBAY
|
+$366M |
| 2 |
CarMax
KMX
|
+$273M |
| 3 |
O'Reilly Automotive
ORLY
|
+$240M |
| 4 |
Motorola Solutions
MSI
|
+$212M |
| 5 |
Alibaba
BABA
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nektar Therapeutics
NKTR
|
+$401M |
| 2 |
TechnipFMC
FTI
|
+$399M |
| 3 |
AutoZone
AZO
|
+$327M |
| 4 |
Cisco
CSCO
|
+$232M |
| 5 |
NetEase
NTES
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.41% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Energy | 13.48% |
| 4 | Healthcare | 12.91% |
| 5 | Technology | 11.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Sabra Healthcare REIT
SBRA
$5.64B
| $566K | ﹤0.01% |
30,155
+13,121
| +77% | +$261K |
|
1452
Myriad Genetics
MYGN
$530M
| $564K | ﹤0.01% |
16,438
-604
| -4% | -$20.4K |
|
1453
National Presto Industries
NPK
$891M
| $564K | ﹤0.01% |
5,669
-1,026
| -15% | -$112K |
|
|
SNI
1454
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $563K | ﹤0.01% |
6,595
+943
| +17% | +$77.9K |
|
|
SRCL
1455
DELISTED
Stericycle Inc
SRCL
| $560K | ﹤0.01% |
8,243
+1,391
| +20% | +$94.4K |
|
|
DISCK
1456
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $559K | ﹤0.01% |
26,386
+3,777
| +17% | +$69.5K |
|
1457
Paychex
PAYX
$40.4B
| $557K | ﹤0.01% |
8,175
+732
| +10% | +$48K |
|
|
ENLC
1458
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $556K | ﹤0.01% |
+31,600
| New | +$519K |
|
1459
Federal Agricultural Mortgage
AGM
$2.27B
| $555K | ﹤0.01% |
7,093
+1,031
| +17% | +$76.5K |
|
1460
Viavi Solutions
VIAV
$9.75B
| $553K | ﹤0.01% |
63,224
+4,838
| +8% | +$43.8K |
|
|
PAY
1461
DELISTED
Verifone Systems Inc
PAY
| $553K | ﹤0.01% |
31,252
-922,202
| -97% | -$17.1M |
|
1462
Warner Bros
WBD
$64.6B
| $552K | ﹤0.01% |
24,658
+3,370
| +16% | +$65.8K |
|
1463
International Flavors & Fragrances
IFF
$19.4B
| $550K | ﹤0.01% |
3,606
+343
| +11% | +$51.5K |
|
1464
New York Times
NYT
$11.6B
| $550K | ﹤0.01% |
29,759
+4,608
| +18% | +$85.6K |
|
|
CHSP
1465
DELISTED
Chesapeake Lodging Trust
CHSP
| $550K | ﹤0.01% |
20,297
+3,574
| +21% | +$100K |
|
1466
Pinnacle West Capital
PNW
$12.9B
| $547K | ﹤0.01% |
6,420
+600
| +10% | +$53K |
|
1467
Haverty Furniture Companies
HVT
$401M
| $545K | ﹤0.01% |
24,072
+1,359
| +6% | +$32.7K |
|
1468
Charles River Laboratories
CRL
$10.9B
| $544K | ﹤0.01% |
4,973
-152,831
| -97% | -$16.6M |
|
|
PRA
1469
DELISTED
ProAssurance
PRA
| $543K | ﹤0.01% |
9,502
-1,563
| -14% | -$91.2K |
|
1470
TransDigm Group
TDG
$69.2B
| $541K | ﹤0.01% |
1,969
+87
| +5% | +$23.6K |
|
|
DRE
1471
DELISTED
Duke Realty Corp.
DRE
| $539K | ﹤0.01% |
19,817
+1,132
| +6% | +$32.2K |
|
|
UNT
1472
DELISTED
UNIT Corporation
UNT
| $539K | ﹤0.01% |
24,533
-1,442
| -6% | -$29.1K |
|
1473
Employers Holdings
EIG
$908M
| $537K | ﹤0.01% |
12,099
-1,509
| -11% | -$71.1K |
|
1474
Enova International
ENVA
$5.91B
| $537K | ﹤0.01% |
35,298
-7,744
| -18% | -$114K |
|
1475
Archrock
AROC
$6.33B
| $536K | ﹤0.01% |
51,084
+3,910
| +8% | +$42.4K |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q4 2017 Portfolio in Review
As of Q4 2017, OppenheimerFunds held 1,933 positions worth $82.8B, up 1.8% from $81.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
OppenheimerFunds's Q4 2017 filing shows 90 new, 882 increased, 857 reduced and 96 closed positions. Its largest new stake was Nebius Group N.V.: 5,110,710 shares worth $167M. The largest sale was Nektar Therapeutics, an estimated $401M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Energy.
- OppenheimerFunds's largest Q4 2017 buy was Nebius Group N.V.: 5,110,710 shares worth $167M.
- OppenheimerFunds added most to eBay in Q4 2017, an estimated $366M increase.
- OppenheimerFunds's biggest Q4 2017 reduction was Nektar Therapeutics, cutting an estimated $401M.
- OppenheimerFunds fully exited NetEase in Q4 2017, selling an estimated $181M.
- OppenheimerFunds's ten largest holdings make up 16% of its $82.8B portfolio in Q4 2017.
- OppenheimerFunds opened 90 new positions and closed 96 in Q4 2017.
- OppenheimerFunds's portfolio value rose 1.8% quarter-over-quarter to $82.8B.
Based on OppenheimerFunds's 13F filing for Q4 2017, filed 12 Feb 2018.